Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

We evaluated the associations of longitudinal 25(OH)D trajectories with subsequent liver stiffness measurement (LSM) increases in patients with early-onset type 2 diabetes and metabolic dysfunction-associated steatotic liver disease.

Source: Abstract. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

After application of the prespecified inclusion and exclusion criteria, 286 patients were included.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Association of longitudinal serum 25-hydroxyvitamin D trajectories with subsequent liver stiffness increase in patients with early-onset type 2 diabetes and metabolic dysfunction-associated steatotic liver disease

Study design awaiting verification · Frontiers in Endocrinology · 2026

Original publication title

Association of longitudinal serum 25-hydroxyvitamin D trajectories with subsequent liver stiffness increase in patients with early-onset type 2 diabetes and metabolic dysfunction-associated steatotic liver disease

Hong Ji; Runzhou Pan; Xiaowei Huang

Copyright © 2026 Ji, Pan and Huang.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

The persistently low 25(OH)D trajectory showed the most consistent association with subsequent LSM increase. The increasing trajectory showed weaker, outcome-definition-dependent associations and coincided with more frequent vitamin D supplementation and a greater reduction in body mass index. These findings should be interpreted as longitudinal associations rather than causal effects or evidence of validated individual-level predictive performance.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

A single serum 25-hydroxyvitamin D [25(OH)D] measurement may not adequately reflect long-term vitamin D exposure. We evaluated the associations of longitudinal 25(OH)D trajectories with subsequent liver stiffness measurement (LSM) increases in patients with early-onset type 2 diabetes and metabolic dysfunction-associated steatotic liver disease.

Source: Background

Abstract: What methods does the paper describe?

This retrospective study included 286 patients managed between 2022 and 2025. Latent class mixed-effects modeling identified 25(OH)D trajectories before a 1-year landmark. The primary outcome was a follow-up LSM value that was both at least 20% (relative) and at least 2.0 kPa (absolute) higher than the landmark value; the conservative sensitivity outcome required increases of at least 30% and at least 3.0 kPa, respectively. Logistic regression models were fitted across 50 pseudo-class draws and pooled using Rubin’s rules. Follow-up LSM was analyzed by analysis of covariance adjusted for landmark LSM and prespecified covariates.

A segmented linear mixed-effects model compared LSM slopes before and after the landmark.

Source: Methods

Abstract: Results

Three trajectories were identified: persistently low (n = 95), increasing (n = 84), and stable high (n = 107). The primary-outcome rates were 54.7%, 33.3%, and 18.7%, respectively. Compared with the stable-high trajectory, the odds ratios in the prespecified primary model were 3.34 (95% confidence interval [CI], 1.68 to 6.61) for the persistently low trajectory and 1.98 (95% CI, 1.03 to 3.82) for the increasing trajectory. After additional adjustment for vitamin D supplementation, cumulative dose, metabolic factors, and medications, the corresponding odds ratios were 2.87 (95% CI, 1.38 to 5.96) and 1.84 (95% CI, 0.91 to 3.72).

Under the conservative outcome definition, the corresponding odds ratios were 3.18 (95% CI, 1.39 to 7.27) and 1.71 (95% CI, 0.76 to 3.84). Adjusted follow-up LSM was higher by 1.07 kPa (95% CI, 0.66 to 1.48) and 0.52 kPa (95% CI, 0.10 to 0.94), respectively. The post-landmark LSM slope exceeded the pre-landmark slope by 0.98 kPa/year (95% CI, 0.80 to 1.16).

Source: Results

Abstract: Conclusions

The persistently low 25(OH)D trajectory showed the most consistent association with subsequent LSM increase. The increasing trajectory showed weaker, outcome-definition-dependent associations and coincided with more frequent vitamin D supplementation and a greater reduction in body mass index. These findings should be interpreted as longitudinal associations rather than causal effects or evidence of validated individual-level predictive performance.

Source: Conclusions
Authors’ abstract

Background

A single serum 25-hydroxyvitamin D [25(OH)D] measurement may not adequately reflect long-term vitamin D exposure. We evaluated the associations of longitudinal 25(OH)D trajectories with subsequent liver stiffness measurement (LSM) increases in patients with early-onset type 2 diabetes and metabolic dysfunction-associated steatotic liver disease.

Methods

This retrospective study included 286 patients managed between 2022 and 2025. Latent class mixed-effects modeling identified 25(OH)D trajectories before a 1-year landmark. The primary outcome was a follow-up LSM value that was both at least 20% (relative) and at least 2.0 kPa (absolute) higher than the landmark value; the conservative sensitivity outcome required increases of at least 30% and at least 3.0 kPa, respectively. Logistic regression models were fitted across 50 pseudo-class draws and pooled using Rubin’s rules. Follow-up LSM was analyzed by analysis of covariance adjusted for landmark LSM and prespecified covariates.

A segmented linear mixed-effects model compared LSM slopes before and after the landmark.

Results

Three trajectories were identified: persistently low (n = 95), increasing (n = 84), and stable high (n = 107). The primary-outcome rates were 54.7%, 33.3%, and 18.7%, respectively. Compared with the stable-high trajectory, the odds ratios in the prespecified primary model were 3.34 (95% confidence interval [CI], 1.68 to 6.61) for the persistently low trajectory and 1.98 (95% CI, 1.03 to 3.82) for the increasing trajectory. After additional adjustment for vitamin D supplementation, cumulative dose, metabolic factors, and medications, the corresponding odds ratios were 2.87 (95% CI, 1.38 to 5.96) and 1.84 (95% CI, 0.91 to 3.72).

Under the conservative outcome definition, the corresponding odds ratios were 3.18 (95% CI, 1.39 to 7.27) and 1.71 (95% CI, 0.76 to 3.84). Adjusted follow-up LSM was higher by 1.07 kPa (95% CI, 0.66 to 1.48) and 0.52 kPa (95% CI, 0.10 to 0.94), respectively. The post-landmark LSM slope exceeded the pre-landmark slope by 0.98 kPa/year (95% CI, 0.80 to 1.16).

Conclusions

The persistently low 25(OH)D trajectory showed the most consistent association with subsequent LSM increase. The increasing trajectory showed weaker, outcome-definition-dependent associations and coincided with more frequent vitamin D supplementation and a greater reduction in body mass index. These findings should be interpreted as longitudinal associations rather than causal effects or evidence of validated individual-level predictive performance.

Publication and source details

Original title: Association of longitudinal serum 25-hydroxyvitamin D trajectories with subsequent liver stiffness increase in patients with early-onset type 2 diabetes and metabolic dysfunction-associated steatotic liver disease

Hong Ji; Runzhou Pan; Xiaowei Huang

Frontiers in Endocrinology · 2026

* Correspondence: Hong Ji, mirelcloud@163.comCopyright © 2026 Ji, Pan and Huang.2026Ji, Pan and Huanghttps://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.The author(s) declared that financial support was received for this work and/or its publication. Self-Funded Project of the Cangzhou Science and Technology Program (No. 23244102100).

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-13T04:18:35.253809+00:00

DOI: 10.3389/fendo.2026.1987830 · PMC13752080